MedTrace Logo

Assessment of What Patients and Healthcare Providers Value

NCT04483349 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 397

Last updated 2022-08-31

No results posted yet for this study

Summary

To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life \[QOL\], cost, experience), and how these patients’ views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).

Conditions

  • Gastric Adenocarcinoma
  • Pancreatic Adenocarcinoma
  • Pancreatic Neuroendocrine Carcinoma

Interventions

OTHER

Survey Administration

Complete survey

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Matthew H Katz · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-11
Primary Completion
2022-08-11
Completion
2022-08-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04483349 on ClinicalTrials.gov